Aytu BioPharma, Inc.AYTUNASDAQ
Loading
Revenue PerformanceStrong
Percentile Rank67
3Y CAGR-16.4%
5Y CAGR-0.9%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
-16.4%/yr
vs +95.7%/yr prior
5Y CAGR
-0.9%/yr
Recent deceleration
Acceleration
-112.2pp
Decelerating
Percentile
P67
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM$62.64M-5.6%
2025$66.38M+1.8%
2024$65.18M-39.3%
2023$107.40M+11.1%
2022$96.67M+47.3%
2021$65.63M+137.5%
2020$27.63M+277.5%
2019$7.32M+100.0%
2018$3.66M+13.6%
2017$3.22M-